The dysregulation of the phosphoinositide 3-kinase (PI3K) signaling pathway has been implicated in the progression and metastasis of human cancers, including colorectal cancers (CRCs), and can frequently be induced by genetic mutations in class IA PI3K. This evidence concerns the gene PIK3CA and cancer.